Close Menu

xTAG

Applied Biocode intends to have panel for identifying 18 gastrointestinal pathogens on the clinical market by the end of the year.

NEW YORK (GenomeWeb) — Luminex reported after the close of the market Monday a 12 percent spike in third quarter revenues driven primarily by growth in assay sales across all major product categories.

NEW YORK (GenomeWeb) – Luminex last week provided an update on nxTAG, its next-generation multiplexing technology in development, pledging a "seamless upgrade" for existing customers of its xTAG bead array products, and promising to have nxTAG in customers' hands by sometime next year.

NEW YORK (GenomeWeb) — Luminex executives this week provided investors with an update on the progress of Aries, the sample-to-answer molecular testing platform that the company plans to launch in Europe later this year and the US next year.

NEW YORK (GenomeWeb) – Luminex said this week that double-digit growth in sales of its xTAG Respiratory Viral and Gastrointestinal Pathogen Panels contributed to an increase in first quarter revenues.

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its first quarter 2014 revenues grew 6 percent, driven by an 18 percent spike in assay sales, as well as an increase in consumables sales.

NEW YORK (GenomeWeb News) – A federal court has dismissed claims against Luminex that had alleged patent infringement.

Luminex is developing a new version of its xTAG PCR chemistry that it believes will improve the ease of use of its technology while maintaining its high-multiplex and high-throughput capabilities.

NEW YORK (GenomeWeb News) – Combinatorial chemistry systems firm Irori Technologies is suing Luminex accusing the Austin, Texas-based firm of infringing three patents with its xMAP and xTAG technologies.

This article was originally posted on Sept. 12.
Luminex has no plans to acquire any new businesses or companies at this time, its CEO Patrick Balthrop said at an investment conference last week.

Pages

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.